Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series
Open Access
- 27 January 2021
- journal article
- research article
- Published by Copernicus GmbH in Journal of Bone and Joint Infection
- Vol. 6 (4) , 85-90
Abstract
A plausible cause of persistent infection after septic hip revision may be the presence of nonviable osteomyelitic bone. Since surgical excision of these necrotic fragments is often challenging, the use of fluorescent tetracycline bone labeling (FTBL) as an intraoperative tool may pose an additional assessment aid to provide a visual index of surgical debridement. Methods: We present a single-center study performed in a university hospital from January 2018 to June 2020, in which all consecutive cases of chronic hip periprosthetic joint infection (PJI) undergoing revision using FTBL were retrospectively reviewed. In all cases, the patient was under treatment with tetracyclines at the moment of the revision surgery. During the surgery, all bone failing to fluoresce was considered nonviable and thus removed and sent for both culture and histology. Results: We include three cases in which the FTBL technique was used. In all cases, the histopathological examinations of the nonfluorescent removed bone were consistent with chronic osteomyelitis. Conclusion: The intraoperative use of FTBL successfully aided the surgeon to detect the presence of nonviable bone in all the presented cases of chronic prosthetic hip infection.Keywords
This publication has 18 references indexed in Scilit:
- How Many Samples and How Many Culture Media To Diagnose a Prosthetic Joint Infection: a Clinical and Microbiological Prospective Multicenter StudyJournal of Clinical Microbiology, 2016
- Similar outcomes between two-stage revisions for infection and aseptic hip revisionsInternational Orthopaedics, 2015
- Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluationOsteoporosis International, 2015
- Fluorescence-guided bone resection by using Visually Enhanced Lesion Scope in diffuse chronic sclerosingosteomyelitis of the mandible: Clinical and pathological evaluationJournal of Clinical and Experimental Dentistry, 2015
- Tetracycline Bone Fluorescence: A Valuable Marker for Osteonecrosis Characterization and TherapyJournal of Oral and Maxillofacial Surgery, 2010
- In vivo tetracycline labeling of bone: an intraoperative aid in the surgical therapy of osteoradionecrosis of the mandibleOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Tetracycline bone labeling in surgical management of chronic osteomyelitis: a case reportJournal of Oral and Maxillofacial Surgery, 2004
- Minimal 11-year follow-up of extensively porous-coated stems in femoral revision total hip arthroplastyThe Journal of Arthroplasty, 2002
- Assessment of Bone Viability in Patients with OsteomyelitisJournal of Orthopaedic Trauma, 1992
- Binding of Tetracyclines to BoneNature, 1965